BR9913288A - Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico - Google Patents

Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico

Info

Publication number
BR9913288A
BR9913288A BR9913288-5A BR9913288A BR9913288A BR 9913288 A BR9913288 A BR 9913288A BR 9913288 A BR9913288 A BR 9913288A BR 9913288 A BR9913288 A BR 9913288A
Authority
BR
Brazil
Prior art keywords
carnitine
acetyl
lipoic acid
alpha
antioxidant composition
Prior art date
Application number
BR9913288-5A
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11406116&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9913288(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Publication of BR9913288A publication Critical patent/BR9913288A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

Patente de Invenção: <B>"COMPOSIçãO ANTIOXIDANTE COMPREENDENDO ACETIL L-CARNITINA E áCIDO ALFA-LIPóICO"<D>. é revelada uma composição que compreende como ingredientes caracterizantes ativos acetil L-carnitina e ácido <244>-lipóico, para prevenção e/ou tratamento terapêutico de várias alterações e estados patológicos induzidos por radicais livres, que podem tomar a forma de um suplemento de dieta, suporte dietético ou de um remédio real.
BR9913288-5A 1998-09-01 1999-08-19 Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico BR9913288A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1998RM000566A IT1302307B1 (it) 1998-09-01 1998-09-01 Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
PCT/IT1999/000268 WO2000011968A1 (en) 1998-09-01 1999-08-19 ANTIOXIDANT COMPOSITION COMPRISING ACETYL L-CARNITINE AND α-LIPOIC ACID

Publications (1)

Publication Number Publication Date
BR9913288A true BR9913288A (pt) 2001-05-22

Family

ID=11406116

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9913288-5A BR9913288A (pt) 1998-09-01 1999-08-19 Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico

Country Status (28)

Country Link
US (1) US6365622B1 (pt)
EP (1) EP1112005B2 (pt)
JP (1) JP4361215B2 (pt)
KR (1) KR20010079699A (pt)
CN (1) CN1315835A (pt)
AR (1) AR022076A1 (pt)
AT (1) ATE228312T1 (pt)
AU (1) AU773424B2 (pt)
BR (1) BR9913288A (pt)
CA (1) CA2341973C (pt)
CZ (1) CZ2001541A3 (pt)
DE (1) DE69904208T3 (pt)
DK (1) DK1112005T4 (pt)
EE (1) EE200100113A (pt)
ES (1) ES2188214T5 (pt)
HK (1) HK1039730A1 (pt)
HU (1) HU229165B1 (pt)
IL (1) IL141435A0 (pt)
IS (1) IS5850A (pt)
IT (1) IT1302307B1 (pt)
MA (1) MA25284A1 (pt)
NO (1) NO20010954L (pt)
PL (1) PL212737B1 (pt)
PT (1) PT1112005E (pt)
SK (1) SK2632001A3 (pt)
TN (1) TNSN99163A1 (pt)
TR (1) TR200100610T2 (pt)
WO (1) WO2000011968A1 (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562869B1 (en) 1999-09-23 2003-05-13 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6479069B1 (en) 1999-09-23 2002-11-12 Juvenon, Inc. Nutritional supplement for increased energy and stamina
US6335361B1 (en) * 1999-11-03 2002-01-01 Juvenon Inc. Method of treating benign forgetfulness
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
JP2010142237A (ja) * 2000-10-31 2010-07-01 Colgate Palmolive Co 組成物及び方法
US20020076470A1 (en) * 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
AU2002232616A1 (en) * 2000-10-31 2002-06-11 Colgate-Palmolive Company Compositions containing an antioxidant such as alpha lipoic acid, carnitine, vitamin C or vitamin E for preventing or inhibiting loss of cognitive function
US6555573B2 (en) 2000-12-21 2003-04-29 The Quigley Corporation Method and composition for the topical treatment of diabetic neuropathy
KR20030088453A (ko) * 2001-03-09 2003-11-19 소시에떼 데 프로듀이 네슬레 소시에떼아노님 연령 관련 생리학적 부전 개선 및 수명 연장을 위한 조성물
SE0102380D0 (sv) * 2001-07-02 2001-07-02 Macronova Ab Kräm för behandling av åldersförändringar i huden hos människa
US6923960B2 (en) 2001-10-03 2005-08-02 Vsl Pharmaceuticals Inc. Antioxidant combination composition and use thereof
CA2470603A1 (en) * 2001-12-19 2003-07-03 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
US20060127505A1 (en) * 2002-01-16 2006-06-15 David Haines Anti-inflammatory formulations
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
AU2003279924A1 (en) * 2002-10-11 2004-05-04 Creagri, Inc. Therapeutic combination of carnitine and antioxidant polyphenols
US7083813B2 (en) 2002-11-06 2006-08-01 The Quigley Corporation Methods for the treatment of peripheral neural and vascular ailments
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
DE10258239A1 (de) * 2002-12-13 2004-06-24 Degussa Ag Formulierung enthaltend alpha-Liponsäure(-Derivate) als alleinigen Wirkstoff bei nichtchronischen alkoholinduzierten Intoxikationen
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
US7999003B2 (en) 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US20050214413A1 (en) * 2003-08-26 2005-09-29 Mannatech, Inc. Methods and compositions for modified release of nutritional supplements
CA2550625C (en) * 2003-12-31 2013-05-28 Integrative Health Consulting, Inc. Nutrient compositions and methods for enhanced effectiveness of the immune system
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
US8569367B2 (en) * 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
AU2005309502B2 (en) * 2004-11-24 2011-11-17 Hill's Pet Nutrition, Inc. Methods for increasing the immune response in an animal
BRPI0518580A2 (pt) * 2004-11-24 2008-11-25 Hills Pet Nutrition Inc mÉtodo para melhorar a depuraÇço hepÁtica de substÂncias xenobiàticas em um animal, kit adequado para alimentar Ácido lipàico a um animal, meio para comunicar informaÇço, composiÇço, e, uso da composiÇço que compreende Ácido lipàico
US20090176864A1 (en) * 2004-11-24 2009-07-09 Hill's Pet Nutrition, Inc. Methods For Improving Hepatic and Immune Function In An Animal
WO2006071919A2 (en) 2004-12-29 2006-07-06 Hill's Pet Nutrition, Inc. Methods for inhibiting a decline in learning and/or memory in animals
CA2592844C (en) * 2004-12-30 2012-10-09 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
US8252742B2 (en) 2004-12-30 2012-08-28 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP5685362B2 (ja) * 2005-04-26 2015-03-18 シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニＳｉｇｍａ−Ｔａｕ Ｉｎｄｕｓｔｒｉｅ Ｆａｒｍａｃｅｕｔｉｃｈｅ Ｒｉｕｎｉｔｅ Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ 有痛性末梢糖尿病性神経障害の予防のためのアセチルｌ−カルニチン
CA2615060C (en) 2005-07-14 2016-06-21 Hill's Pet Nutrition, Inc. Method for prolonging the life of animals
CA2664982C (en) * 2006-02-23 2015-12-29 Nou-Life Sciences, Inc. Cleavable carnitine compound
CN101045048B (zh) * 2006-03-27 2011-05-18 中国科学院上海生命科学研究院 线粒体营养素组合物的应用
CN101057857B (zh) * 2006-04-21 2011-05-18 中国科学院上海生命科学研究院 一种预防与改善帕金森氏症的组合物及其制法
KR100811110B1 (ko) * 2007-02-21 2008-03-06 주식회사 디피아이 솔루션스 수분산성 α-리포산 캡슐 조성물을 함유하는 어류의 면역력증강용 사료첨가제 및 그 사용방법.
US20080226696A1 (en) * 2007-03-15 2008-09-18 Ben Treadwell Methods of improving learning abilities of aged companion animals
US20100255109A1 (en) * 2007-08-06 2010-10-07 Biogenics, Inc. Stabilized antioxidant particles, composition comprising the same and method for preparing the same
KR20090014568A (ko) * 2007-08-06 2009-02-11 (주)바이오제닉스 코팅된 알파리포산 입자, 이를 포함하는 조성물 및 그 제조방법
US20090054513A1 (en) * 2007-08-22 2009-02-26 Response Scientific, Inc. Method of managing blood glucose levels, insulin levels and/or insulin receptor functionality in individuals with diabetes, polycystic ovarian syndrome and/or alzheimer's disease
US7943163B2 (en) * 2007-08-22 2011-05-17 Response Scientific, Inc. Medical food or nutritional supplement, method of manufacturing same, and method of managing diabetes
KR100903549B1 (ko) * 2008-07-29 2009-06-23 주식회사 카이로제닉스 균질한 결정성의 아세틸-ｌ-카르니틴과 티옥트산 칼륨염의 복합염, 이의 제조방법 및 이를 포함하는 약학적 조성물
US20110217252A1 (en) * 2008-11-11 2011-09-08 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Compound useful for treating cellulite
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
US9040082B2 (en) 2011-06-24 2015-05-26 K-Pax Pharmaceuticals, Inc. Compositions and methods for treatment of chronic fatigue
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
KR102017922B1 (ko) 2011-12-07 2019-09-03 알러간, 인코포레이티드 염-민감성 유액 시스템을 사용한 사람 눈물막으로의 효율적인 지질 전달 방법
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US20140371280A1 (en) * 2013-03-15 2014-12-18 Shinichi Okuyama Method of treating diabetic peripheral neuropathy through amendment of pre-neuronal diabetic coagulative micro-angiopathy and neuronal deficiency of mitochondrial ATP production, and through induction of neuronal regeneration
CA2965671A1 (en) * 2014-10-24 2016-04-28 Robert Shorr Methods and compositions for the treatment of pre-diabetes, diabetes and metabolic syndrome
UA121399C2 (uk) 2014-11-25 2020-05-25 Аллерган, Інк. Стабілізовані композиції для офтальмологічного застосування, які містять омега-3-кислоти
DK3277273T3 (da) * 2015-03-31 2020-04-14 Kolinpharma S P A Sammensætning til behandling af neuropatier og/eller neuropatisk smerte
JP6918782B2 (ja) * 2015-08-24 2021-08-11 ヴィトロライフ スウェーデン アクチボラゲット 培養培地
US20220211724A1 (en) * 2018-09-10 2022-07-07 URlACH ITALY S.R.L. Composition comprising lipoic acid and vitamin d for the prevention and the treatment of neurodegenerative diseases and peripheral neuropathies
CN111467385B (zh) * 2019-01-24 2022-05-17 深圳市华大农业应用研究院 组合物在预防或治疗神经退行性疾病中的用途
ES2889587T3 (es) * 2019-04-18 2022-01-12 Simo Rasi Composición para su uso en la prevención o reducción del estrés oxidativo y de enfermedades neurodegenerativas
WO2022215085A1 (en) * 2021-04-06 2022-10-13 Celagenex Research (India) Pvt. Ltd. A synergistic composition for potentiating stabilized atp
CN112999220B (zh) * 2021-04-07 2022-12-13 中国人民解放军南部战区总医院 α-硫辛酸在作为和/或制备金属β-内酰胺酶抑制剂中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668117A (en) 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
AU6482596A (en) 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
IT1283967B1 (it) 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi
US5977162A (en) 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
WO1998033494A1 (en) 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US5916912A (en) * 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress

Also Published As

Publication number Publication date
TNSN99163A1 (fr) 2005-11-10
IS5850A (is) 2001-02-16
MA25284A1 (fr) 2001-12-31
DE69904208D1 (de) 2003-01-09
CA2341973C (en) 2009-05-12
PT1112005E (pt) 2003-03-31
ATE228312T1 (de) 2002-12-15
AU773424B2 (en) 2004-05-27
IT1302307B1 (it) 2000-09-05
US6365622B1 (en) 2002-04-02
EP1112005B1 (en) 2002-11-27
ITRM980566A0 (it) 1998-09-01
EP1112005A1 (en) 2001-07-04
EE200100113A (et) 2002-06-17
HU229165B1 (en) 2013-09-30
EP1112005B2 (en) 2010-03-24
HUP0102909A2 (hu) 2002-03-28
WO2000011968A1 (en) 2000-03-09
NO20010954L (no) 2001-04-25
AR022076A1 (es) 2002-09-04
PL346318A1 (en) 2002-01-28
DE69904208T2 (de) 2003-08-28
IL141435A0 (en) 2002-03-10
ITRM980566A1 (it) 2000-03-01
CN1315835A (zh) 2001-10-03
NO20010954D0 (no) 2001-02-26
JP2002523435A (ja) 2002-07-30
DK1112005T3 (da) 2002-12-30
CA2341973A1 (en) 2000-03-09
KR20010079699A (ko) 2001-08-22
PL212737B1 (pl) 2012-11-30
AU5387199A (en) 2000-03-21
DK1112005T4 (da) 2010-06-14
HK1039730A1 (zh) 2002-05-10
JP4361215B2 (ja) 2009-11-11
CZ2001541A3 (cs) 2001-09-12
SK2632001A3 (en) 2001-08-06
DE69904208T3 (de) 2010-09-30
ES2188214T5 (es) 2010-06-08
WO2000011968A8 (en) 2000-05-11
TR200100610T2 (tr) 2001-07-23
ES2188214T3 (es) 2003-06-16
HUP0102909A3 (en) 2002-12-28

Similar Documents

Publication Publication Date Title
BR9913288A (pt) Composição antioxidante compreendendo acetil l-carnitina e ácido alfa-lipóico
BR9911440A (pt) Composição para a prevenção e/ou tratamento de osteoporose e alterações devido à sìndrome de menopausa
BR9912179A (pt) Composição neuroprotetora para a prevenção e/ou tratamento de alterações nervosas e do comportamento devido a estados de ansiedade ou depressão
BR0010113A (pt) Preparações para uso externo na pele
BR0112799A (pt) Composição farmacêutica, processo para preparação e utilização da mesma, conjunto e processo para tratamento de obesidade, utilização de um inibidor de lìpase e de um sequestrante de ácido de bìlis e processo de tratamento ou prevencão de efeitos colaterais gastrointestinais
BR0206381A (pt) Derivados do ácido fumárico como inibidor de nf-kappab
BRPI0512213A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0407950A (pt) processo para a preparação de uma composição de higiene pessoal
BR9814327A (pt) Compostos de tiouréia e benzamida, composições e pro-cessos para tratamento ou prevenção de doenças infla-matórias e arteriosclerose
GB0129260D0 (en) Pharmaceutical compositions and their uses
BRPI0512220A (pt) método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto
BRPI0410170A (pt) preparação e uso de derivados de ácido aril alquìlico para o tratamento de obesidade
BRPI0415121A (pt) material particulado, forma de dosagem sólida, método para fabricar a mesma, e, uso de um material particulado ou de uma forma de dosagem sólida
BR0107157A (pt) Diagnose e tratamento de condições cardiovasculares
BR0008059A (pt) Composições de valdecoxib
BR9915918A (pt) Combinação de carnitinas e resveratrol para prevenção ou tratamento de distúrbios cerebrais ou de envelhecimento
BR0006045A (pt) Composição que compreende uma carnitina e glutationa, útil para aumentar a absorção de glutationa e para sinergizar seus efeitos
BR0313630A (pt) Composição para aplicação tópica, sistema para o tratamento de caspa, métodos para o tratamento e/ou prevenção da caspa e da coceira do couro cabeludo e usos de uma combinação sinérgica
BR0312845A (pt) Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
BR0112337A (pt) Derivados de fosfolipìdeos de ácido valpróico e suas misturas
BR0210013A (pt) Gel oftálmico de pirenzepina
BRPI0411176A (pt) combinação farmacêutica consistindo de modafinil e outra droga
BR9912703A (pt) Composição antioxidante, antiprolìfera, compreendendo uma carnitina e um carotenóide
BR9814214A (pt) Composição com ácido azeláico
BRPI0411665A (pt) uso de agomelatina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica ou kit, e, métodos para o tratamento de doenças ou distúrbios responsivos a um inibidor da recaptação de serotonina e para aumentar e/ou proporcionar inìcio mais rápido do efeito terapêutico de um inibidor da recaptação de serotonina

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/385 (2006.01), A23L 33/12 (2016.0